Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Continuous infusion carboplatin on a 21-day schedule: a phase I and pharmacokinetic study.
- E. Smit, P. Willemse, +6 authors E. D. de Vries
- Medicine
- Journal of clinical oncology : official journal…
- 1991
A phase I study with continuous infusion carboplatin for 21 days every 6 weeks using a venous access port and portable pump was performed over a dose range of 12 to 32 mg/m2/d, with increments of 2… Expand
A role for mast cells and the vasoactive amine serotonin in T cell-dependent immunity to tumors.
- H. van Loveren, W. den Otter, R. Meade, P. Terheggen, P. Askenase
- Biology, Medicine
- Journal of immunology
- 1 February 1985
The involvement of mast cells in anti-tumor resistance was studied by employing 2 strains of mast cell deficient but otherwise immunocompetent mice on a C57BL/6 (H-2b) background (W/Wv and Sl/Sld)… Expand
Immunocytochemical detection of interaction products of cis-diamminedichloroplatinum(II) and cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II) with DNA in rodent tissue sections.
- P. Terheggen, B. Floot, E. Scherer, A. Begg, A. M. Fichtinger-Schepman, L. den Engelse
- Biology, Medicine
- Cancer research
- 15 December 1987
Calf thymus DNA was modified in vitro by cis-diamminedichloroplatinum(II) (cisDDP), complexed with methylated bovine serum albumin and used to immunize rabbits. The anti-cisDDP-DNA antiserum obtained… Expand
Correlation between cell killing by cis-diamminedichloroplatinum(II) in six mammalian cell lines and binding of a cis-diamminedichloroplatinum(II)-DNA antiserum.
- P. Terheggen, J. Emondt, +4 authors A. Begg
- Medicine, Biology
- Cancer research
- 15 June 1990
The relationship between cell killing and the binding of the anticancer drug cis-diamminedichloroplatinum(II) (cis-DDP) to DNA was studied in six mammalian cell lines. Two of the human cell lines… Expand
Immunocytochemical analysis of DNA adducts in single cells: a new tool for experimental carcinogenesis, chemotherapy and molecular epidemiology.
- E. Scherer, J. van Benthem, P. Terheggen, E. Vermeulen, H. Winterwerp, L. den Engelse
- Biology, Medicine
- IARC scientific publications
- 1988
The immunocytochemical staining of carcinogen-DNA adducts by a double peroxidase-anti-peroxidase (PAP) method is critically described. It is a powerful new tool for the investigation of the initial… Expand
Dose-escalation study of carboplatin (day 1) and cisplatin (day 3): tolerance and relation to leukocyte and buccal cell platinum--DNA adducts.
- I. Gill, F. Muggia, +7 authors L. den Engelse
- Medicine
- Annals of oncology : official journal of the…
- 1 February 1991
Carboplatin and cisplatin have similar antitumor activities but different toxicities. Combining these two analogs may be expected to balance the toxicities and allow higher doses of platinum… Expand
Monitoring of interaction products of cis-diamminedichloroplatinum(II) and cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II) with DNA in cells from platinum-treated cancer patients.
- P. Terheggen, R. Dijkman, +4 authors L. den Engelse
- Chemistry, Medicine
- Cancer research
- 1 October 1988
The formation and stability of interaction products between the anti-cancer drug cis-diamminedichloroplatinum(II) (cis-DDP) and DNA were studied in buccal epithelial and urinary cells from ten cancer… Expand
Cellular distribution of cis-diamminedichloroplatinum(II)-DNA binding in rat dorsal root spinal ganglia: effect of the neuroprotecting peptide ORG.2766.
- P. Terheggen, R. G. van der Hoop, B. Floot, W. Gispen
- Biology, Medicine
- Toxicology and applied pharmacology
- 15 June 1989
The in situ binding of the anticancer drug cis-diamminedichloroplatinum(II) (cisDDP) to DNA was studied in the rat dorsal root spinal ganglion (DRG), using an antiserum against cisDDP-modified calf… Expand
Drug-induced DNA modification in buccal cells of cancer patients receiving carboplatin and cisplatin combination chemotherapy, as determined by an immunocytochemical method: interindividual variation…
- F. A. Blommaert, C. Michael, +5 authors L. den Engelse
- Chemistry, Medicine
- Cancer research
- 1 December 1993
Twenty-six patients with a variety of tumor types were treated according to a phase 1 experimental treatment protocol consisting of repetitive cycles of… Expand
Formation of interaction products of carboplatin with DNA in vitro and in cancer patients.
- P. Terheggen, A. Begg, J. Emondt, R. Dubbelman, B. Floot, L. den Engelse
- Chemistry, Medicine
- British Journal of Cancer
- 1 February 1991
Binding of the cytostatic drug carboplatin to DNA was studied in solution, in RIF-1 and CHO cell lines and in human buccal cells after in vitro or in situ drug exposure. Results were compared with… Expand